Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.36 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | XBP1 | P17861 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12401856 | 0.85 | SMN1; SMN2 (0.42) | ALDH1A1CYP3A4POLBSMN1; SMN2 | |
| SCHEMBL12020341 | 0.85 | GABBR2 (0.36) | GABBR2GABBR1SMN1; SMN2MAPK1GABRA1 | |
| SCHEMBL14452703 | 0.82 | GABBR2 (0.37) | GABBR2GABBR1ALDH1A1POLBMAPK1 | |
| SCHEMBL21346939 | 0.81 | GABBR2 (0.35) | GABBR2GABBR1 | |
| SCHEMBL12217127 | 0.81 | ALDH1A1 (0.33) | ALDH1A1CYP3A4POLBSMN1; SMN2MAPK1 | |
| SCHEMBL15828714 | 0.80 | CYP2C19 (0.36) | ALDH1A1CYP3A4POLBSMN1; SMN2MAPK1 | |
| SCHEMBL12401759 | 0.79 | ALDH1A1 (0.32) | ALDH1A1CYP3A4POLBSMN1; SMN2 | |
| SCHEMBL12217144 | 0.79 | NPC1 (0.34) | ALDH1A1CYP3A4SMN1; SMN2MAPK1LMNA | |
| SCHEMBL19648626 | 0.79 | ELANE (0.36) | GABBR2GABBR1GABRA1GABRB2 | |
| SCHEMBL12118453 | 0.79 | ALDH1A1 (0.39) | ALDH1A1CYP3A4SMN1; SMN2MAPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9293789-B2 | Redox shuttles for lithium ion batteries | UCHICAGO ARGONNE, LLC (US) | 2016-03-22 | — | — | US | claimed |
| US-20150037691-A1 | REDOX SHUTTLES FOR LITHIUM ION BATTERIES | ENERGY, UNITED STATES DEPARTMENT OF | 2015-02-05 | — | — | US | claimed |
| US-8877390-B2 | Redox shuttles for lithium ion batteries | UCHICAGO ARGONNE, LLC (US) | 2014-11-04 | — | — | US | claimed |
| US-20110294017-A1 | REDOX SHUTTLES FOR LITHIUM ION BATTERIES | ENERGY, UNITED STATES DEPARTMENT OF | 2011-12-01 | — | — | US | claimed |
| US-12600858-B2 | Ion selective membranes for organic electrochemical processes | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2026-04-14 | — | — | US | disclosed |
| US-11916198-B2 | Fast-charging lithium ion batteries with electrolytes that do not react on the anodes | StoreDot Ltd. (IL) | 2024-02-27 | — | — | US | disclosed |
| US-20230099030-A1 | ION SELECTIVE MEMBRANES FOR ORGANIC ELECTROCHEMICAL PROCESSES | NATIONAL SCIENCE FOUNDATION | 2023-03-30 | — | — | US | disclosed |
| US-11271237-B2 | Organic redox molecules for flow batteries | UCHICAGO ARGONNE, LLC (US) | 2022-03-08 | — | — | US | disclosed |
| WO-2021188977-A1 | ION SELECTIVE MEMBRANES FOR ORGANIC ELECTROCHEMICAL PROCESSES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2021-09-23 | — | — | WO | disclosed |
| US-20210203002-A1 | FAST-CHARGING LITHIUM ION BATTERIES WITH ELECTROLYTES THAT DO NOT REACT ON THE ANODES | StoreDot Ltd. (IL) | 2021-07-01 | — | — | US | disclosed |
| US-20210036355-A1 | ORGANIC REDOX MOLECULES FOR FLOW BATTERIES | UNITED STATES DEPARTMENT OF ENERGY | 2021-02-04 | — | — | US | disclosed |
| US-10424806-B2 | Organic non-aqueous cation-based redox flow batteries | UCHICAGO ARGONNE, LLC (US) | 2019-09-24 | — | — | US | disclosed |
| US-8877390-B2 | Redox shuttles for lithium ion batteries | UCHICAGO ARGONNE, LLC (US) | 2014-11-04 | — | — | US | disclosed |
| US-8877390-B2 | Redox shuttles for lithium ion batteries | UCHICAGO ARGONNE, LLC (US) | 2014-11-04 | — | — | US | disclosed |
| US-8877390-B2 | Redox shuttles for lithium ion batteries | UCHICAGO ARGONNE, LLC (US) | 2014-11-04 | — | — | US | disclosed |
| WO-2014090877-A1 | (HETERO)AROMATIC ISO(THIO)CYANATES AS REDOX SHUTTLE ADDITIVES FOR ELECTROCHEMICAL CELLS | Rockwood Lithium GmbH (DE) | 2014-06-19 | — | — | WO | disclosed |
| US-20130224538-A1 | ORGANIC NON-AQUEOUS CATION-BASED REDOX FLOW BATTERIES | UCHICAGO ARGONNE LLC (US) | 2013-08-29 | — | — | US | disclosed |
| US-20110294017-A1 | REDOX SHUTTLES FOR LITHIUM ION BATTERIES | ENERGY, UNITED STATES DEPARTMENT OF | 2011-12-01 | — | — | US | disclosed |
| US-20110294017-A1 | REDOX SHUTTLES FOR LITHIUM ION BATTERIES | ENERGY, UNITED STATES DEPARTMENT OF | 2011-12-01 | — | — | US | disclosed |
| US-20110294017-A1 | REDOX SHUTTLES FOR LITHIUM ION BATTERIES | ENERGY, UNITED STATES DEPARTMENT OF | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11271237-B2 | Organic redox molecules for flow batteries | GPX1, LPO, GPX4 | GABBR2 4132/4885GABBR1 4119/4885ALDH1A1 286/4885 |
| US-12600858-B2 | Ion selective membranes for organic electrochemical processes | PHOSPHO1, SLC6A12, VDAC3 | GABBR2 3325/4885GABBR1 2979/4885ALDH1A1 1898/4885 |
| US-20210036355-A1 | ORGANIC REDOX MOLECULES FOR FLOW BATTERIES | GPX1, LPO, GPX4 | GABBR2 4132/4885GABBR1 4119/4885ALDH1A1 286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.